Dual-Blockade Immune Checkpoint for Breast Cancer Treatment Based on a Tumor-Penetrating Peptide Assembling Nanoparticle | ACS Applied Materials & Interfaces
What Breast Medical Oncologists Need From Pathologists: Overview, Tumor Size, Histologic Grade
Midkine expression by stem-like tumor cells drives persistence to mTOR inhibition and an immune-suppressive microenvironment | Nature Communications
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
Diagnostics | Free Full-Text | The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity
Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy | ACS Combinatorial Science
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
IJMS | Free Full-Text | Macrophage Polarization States in the Tumor Microenvironment
Prostate cancer - Wikipedia
Pancreatic cancer - Wikipedia
Cancers | Free Full-Text | Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives
Circulating tumour cells in the -omics era: how far are we from achieving the 'singularity'? | British Journal of Cancer
Papillary thyroid cancer - Wikipedia
A blood tumor marker combination assay produces high sensitivity and specificity for cancer according to the natural history - Kobayashi - 2018 - Cancer Medicine - Wiley Online Library
Frontiers | The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment
Frontiers | Cross Talk Between Macrophages and Cancer Cells in the Bone Metastatic Environment
Protein Tumor Markers
Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer | Science Advances
Tumor Marker Test, Types of Tumor Markers,Tumor Marker Test Price | Hipro Biotechnology
Frontiers | IDO Expression in Cancer: Different Compartment, Different Functionality?
Inflammation and tumor progression: signaling pathways and targeted intervention | Signal Transduction and Targeted Therapy
Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer | Nature Communications
Which Tumor Marker Can Be Used to Assess Stage, Prognosis, Response to Treatment? | ONS Voice
Spatiotemporal co-dependency between macrophages and exhausted CD8+ T cells in cancer - ScienceDirect
Pan-cancer single-cell landscape of tumor-infiltrating T cells | Science
Co-evolution of tumor and immune cells during progression of multiple myeloma | Nature Communications
